What is the conversion ratio from hydrocodone (opioid analgesic) to oxycodone (opioid analgesic) for pain management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydrocodone to Oxycodone Conversion

When converting from hydrocodone to oxycodone, use a ratio of approximately 1:0.67 (or 1.5:1 in reverse), meaning 10 mg of hydrocodone equals approximately 6.7 mg of oxycodone, but always reduce the calculated dose by 25-50% to account for incomplete cross-tolerance. 1

Conversion Calculation Method

Using the CDC's morphine milligram equivalent (MME) conversion factors: 1

  • Hydrocodone has a conversion factor of 1.0 (meaning 1 mg hydrocodone = 1 MME)
  • Oxycodone has a conversion factor of 1.5 (meaning 1 mg oxycodone = 1.5 MME)

Step-by-Step Algorithm:

  1. Calculate total daily hydrocodone dose - Add all hydrocodone doses taken in 24 hours 1

  2. Convert to MME - Multiply hydrocodone dose by 1.0 (the dose stays the same in MME) 1

  3. Calculate theoretical oxycodone equivalent - Divide the MME by 1.5 to get the oxycodone dose 1

    • Example: 30 mg hydrocodone daily = 30 MME ÷ 1.5 = 20 mg oxycodone daily
  4. Apply safety reduction of 25-50% - This is the most critical step 1

    • If pain was well-controlled: reduce by 50% (use 10 mg oxycodone in above example)
    • If pain was poorly controlled: reduce by 25% (use 15 mg oxycodone in above example)

Critical Safety Considerations

Never use the calculated MME dose directly when converting between opioids - the CDC explicitly warns that equianalgesic conversions cannot account for incomplete cross-tolerance and individual pharmacokinetic variability. 1

Key Safety Points:

  • Incomplete cross-tolerance means patients don't have full tolerance to the new opioid even if tolerant to the previous one, creating overdose risk 1

  • Individual variability in genetics and pharmacokinetics makes conversions unpredictable 1, 2

  • Always prescribe breakthrough medication during the conversion period, typically 10-15% of the total daily dose as needed every 2-4 hours 1

Common Clinical Scenarios

Example 1: Well-Controlled Pain

Patient on hydrocodone 10 mg four times daily (40 mg/day total):

  • 40 mg hydrocodone = 40 MME
  • 40 MME ÷ 1.5 = 26.7 mg oxycodone theoretical dose
  • Apply 50% reduction: Start with 13-15 mg oxycodone daily (e.g., 5 mg three times daily) 1

Example 2: Poorly Controlled Pain

Same patient with inadequate pain relief:

  • 40 mg hydrocodone = 40 MME
  • 40 MME ÷ 1.5 = 26.7 mg oxycodone theoretical dose
  • Apply 25% reduction: Start with 20 mg oxycodone daily (e.g., 5 mg four times daily or 10 mg twice daily if using extended-release) 1

Monitoring and Titration

Reassess within 24-48 hours of conversion to evaluate pain control and adverse effects 3

  • Monitor for oversedation, respiratory depression, or inadequate analgesia 1
  • Titrate based on breakthrough medication requirements 1, 3
  • The peak respiratory depressant effect may occur at different times than peak analgesic effect 1

Important Caveats

Opioid rotation is indicated when the adverse effect/analgesic equation is skewed toward side effects despite aggressive adjuvant treatment 1

  • Studies show 10-30% of patients on one opioid don't achieve successful outcomes but may respond better to another opioid 1
  • The conversion ratio remains somewhat unpredictable due to asymmetric tolerance and different pharmacokinetic profiles 1, 4
  • Research demonstrates significant variability in how clinicians perform these conversions, with large standard deviations in practice 2

Avoid dosage increases when possible - many patients don't experience benefit in pain or function from increasing opioid dosages but are exposed to progressive increases in risk 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Variability in Opioid Equivalence Calculations.

Pain medicine (Malden, Mass.), 2016

Guideline

Opioid Conversion Guidelines for Hydromorphone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.